Is there a Lao generic version of Gilteritinib?

Giritinib is a drug used to treat FLT3(FMS-like tyrosine kinase 3) mutation-positive acute myeloid leukemia (FLT3-positive acute myeloid leukemia, AML). FLT3Mutation-positiveAML is a subtype of leukemia, in which FLT3Gene mutations lead to abnormal activation of the FLT3 signaling pathway and promote the abnormal proliferation and growth of AML cells. Giritinib helps control the growth of leukemia cells by inhibiting the activity of FLT3 receptor tyrosine kinase.

There is a Laotian generic version of Giritinib, which costs about four to five thousand yuan, which is relatively cheap. In terms of drug ingredients, the ingredients of domestic and foreign original gilitinib drugs are basically the same as those of generic drugs.

Giritinib is currently on the market in China, but it is not included in medical insurance. If patients need it, they can go to the hospital to buy it at their own expense, but the price is very high, about about 35,000 yuan. For specific prices, please consult the local hospital pharmacy. Foreign original drugs of gilitinib are even more expensive. For example, the price of the Hong Kong version of the original drug is around 90,000 yuan, and the European version of the original drug is as high as more than 200,000 yuan, which is simply unaffordable for ordinary patients.

Giritinib is a new drug targetingFLT3mutation-positiveAML. It helps control the growth and spread of leukemia by inhibiting the activity of abnormal signaling pathways. It has been approved by the FDA to treat this specific type of AML, improving patient survival and quality of life.

While giritinib has many benefits, it can also cause some side effects and needs to be used under a doctor's supervision. For patients withFLT3mutation-positiveAMLFor patients, giritinib is an important treatment option that is expected to help them control the disease and improve survival rates.